Published in Clinics (Sao Paulo) on January 01, 2012
Management of pancreatic neuroendocrine tumors in patients with MEN 1. Gland Surg (2015) 0.85
A differential diagnosis of inherited endocrine tumors and their tumor counterparts. Clinics (Sao Paulo) (2013) 0.77
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Genetic aspects of adenomatosis of endocrine glands. Am J Med (1954) 4.60
Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med (1999) 3.21
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat (2008) 2.27
Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med (1990) 2.12
Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res (2008) 1.98
Insulinoma. Best Pract Res Clin Gastroenterol (2005) 1.80
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg (2010) 1.48
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg (2004) 1.45
Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab (2005) 1.40
Lethality of multiple endocrine neoplasia type I. World J Surg (1998) 1.35
Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg (2006) 1.34
Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery (1991) 1.29
Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg (2006) 1.19
Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg (2000) 1.18
Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery (2000) 1.13
Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer (1986) 1.11
Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome. Ann Surg (1989) 1.08
Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab (1991) 1.08
Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg (1999) 1.07
Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol Clin Biol (2004) 1.07
Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg (2000) 1.06
Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg (1995) 1.06
Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med (1998) 1.05
Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg (2006) 1.03
Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol (2005) 1.00
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg (2008) 0.98
Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg (1998) 0.98
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg (2005) 0.98
Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab (2007) 0.98
Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res (2000) 0.98
Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg (2004) 0.97
Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery (1998) 0.97
The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery (2004) 0.95
Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization? World J Surg (1998) 0.95
Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg (2002) 0.94
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg (2002) 0.94
Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol (2011) 0.94
Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am (2009) 0.92
Role of surgery in Zollinger-Ellison syndrome. J Am Coll Surg (2007) 0.92
Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg (1996) 0.90
Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol (2000) 0.90
Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg (2011) 0.88
Curative resection of microgastrinomas based on the intraoperative secretin test. World J Surg (2000) 0.86
New pancreas-preserving total duodenectomy technique. World J Surg (2005) 0.85
Duodenal gastrinoma: the solution to the pancreatic paradox. J Clin Gastroenterol (1994) 0.84
Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab (1992) 0.84
Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery (2007) 0.83
Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg (2003) 0.81
Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg (1992) 0.81
Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. Br J Surg (2005) 0.80
Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor. Best Pract Res Clin Gastroenterol (2005) 0.80
Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. J Intern Med (2005) 0.80
The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery (2008) 0.79
Surgical treatment of endocrine pancreatic lesions in MEN-1. Acta Oncol (1991) 0.79
Total pancreatectomy in the MEN-1 syndrome. Br J Surg (1988) 0.78
Multiple endocrine neoplasia type 1: duodenopancreatic tumours. J Intern Med (2003) 0.78
Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg (2004) 0.78
Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery (2009) 0.76
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation (2009) 2.85
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet (2013) 2.09
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int (2010) 1.70
Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J Clin Endocrinol Metab (2013) 1.69
Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr (2010) 1.64
Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab (2010) 1.43
Imaging for primary hyperparathyroidism--an evidence-based analysis. Langenbecks Arch Surg (2009) 1.30
Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One (2012) 1.30
Management of midgut carcinoids. J Surg Oncol (2005) 1.28
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab (2002) 1.24
Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab (2007) 1.21
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol (2010) 1.15
Surgical treatment of Graves' disease: evidence-based approach. World J Surg (2008) 1.15
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab (2006) 1.11
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer (2010) 1.11
Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) (2009) 1.10
Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg (2012) 1.07
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol (2014) 1.05
Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors. World J Surg (2008) 1.05
Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail (2010) 1.05
25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res (2005) 1.01
Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol (2005) 1.00
High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg (2008) 0.97
Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine. Eur J Cancer (2008) 0.97
Association of parathyroid adenoma and pregnancy with preeclampsia. J Clin Endocrinol Metab (2009) 0.96
Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol (2005) 0.95
Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg (2009) 0.95
Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes Chromosomes Cancer (2012) 0.93
Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am (2009) 0.92
Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses. World J Surg (2010) 0.91
Long-term survival of patients with small intestinal carcinoid tumors. World J Surg (2004) 0.91
Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) (2002) 0.91
Prognostic relevance of survivin in pancreatic endocrine tumors. World J Surg (2012) 0.91
Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol (2006) 0.89
Parathyroid glands in calcium regulation and human disease. Ann N Y Acad Sci (2005) 0.89
Left-shifted relation between calcium and parathyroid hormone in obesity. J Clin Endocrinol Metab (2010) 0.89
Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Eur J Radiol (2007) 0.88
Primary hyperparathyroidism. Curr Opin Oncol (2004) 0.85
Different gene expression profiles in metastasizing midgut carcinoid tumors. Endocr Relat Cancer (2011) 0.85
Left-shifted relation between calcium and parathyroid hormone in Graves' disease. J Clin Endocrinol Metab (2013) 0.85
Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin Endocrinol (Oxf) (2007) 0.85
Management of Grave's disease is improved by total thyroidectomy. World J Surg (2012) 0.84
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma. Endocr Connect (2013) 0.84
Surgical aspects of neuroendocrine tumours. Eur J Cancer (2009) 0.83
Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d. J Clin Endocrinol Metab (2002) 0.82
Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report. J Med Case Rep (2010) 0.82
TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors. Endocr Relat Cancer (2014) 0.81
Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology (2004) 0.81
Prophylactic cholecystectomy in midgut carcinoid patients. World J Surg (2010) 0.81
Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells. Pancreas (2009) 0.80
Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells. J Steroid Biochem Mol Biol (2004) 0.78
Gastrointestinal stromal tumors express the orexigen ghrelin. Endocr Relat Cancer (2006) 0.78
Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography. BMC Med Imaging (2009) 0.78
MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours. Fam Cancer (2014) 0.78
Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors. Endocr Relat Cancer (2014) 0.78
Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall? World J Surg (2013) 0.77
Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer (2011) 0.77
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors. Endocr Relat Cancer (2014) 0.77
Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor. Endocrinology (2012) 0.76
11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years. J Clin Endocrinol Metab (2012) 0.76
Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells. Clin Endocrinol (Oxf) (2007) 0.76
Culture of parathyroid cells. Methods Mol Biol (2012) 0.76
Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays. Anticancer Res (2009) 0.76
PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours. Cancers (Basel) (2012) 0.75
DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors. Neuroendocrinology (2016) 0.75
Malignant insulinoma in ectopic pancreatic tissue. Dig Surg (2004) 0.75
(11)C-hydroxyephedrine positron emission tomography in the postoperative management of pheochromocytoma and paraganglioma. Neuroendocrinology (2014) 0.75
An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors. Int J Gynecol Cancer (2016) 0.75
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases. Nucl Med Biol (2012) 0.75
[Repeated non-epileptic seizures in a previously healthy young woman - a case report]. Laeknabladid (2016) 0.75
Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemia. Surgery (2002) 0.75
[A case report. FDG-PET in occult breast cancer]. Lakartidningen (2002) 0.75
Indication for liver transplantation in young patients with small intestinal NETs is rare? World J Surg (2014) 0.75